Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.4700
+0.3600 (327.27%)
Oct 7, 2025, 8:00 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Therapies
515.00K
Log In
Log In
Log In
Log In
Upgrade
Therapies Growth
-91.99%
Log In
Log In
Log In
Log In
Upgrade
Octomera
68.00K
Log In
Log In
Log In
Log In
Upgrade
Octomera Growth
-99.81%
Log In
Log In
Log In
Log In
Upgrade
Eliminations
-53.00K
Log In
Log In
Log In
Log In
Upgrade
Eliminations Growth
-99.05%
Log In
Log In
Log In
Log In
Upgrade
Point-of-Care and Hospital Services
-
Log In
Log In
Log In
Log In
Upgrade
Point-of-Care and Hospital Services Growth
-
Log In
Log In
Log In
Log In
Upgrade
Cell Process Development Services
-
Log In
Log In
Log In
Log In
Upgrade
Cell Process Development Services Growth
-
Log In
Log In
Log In
Log In
Upgrade
Contract Development and Manufacturing Organization
-
Log In
Log In
Log In
Log In
Upgrade
Contract Development and Manufacturing Organization Growth
-
Log In
Log In
Log In
Log In
Upgrade
Point-of-Care Cell Therapy Services
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Belgium
530.00K
Log In
Log In
Log In
Log In
Upgrade
Belgium Growth
-98.53%
Log In
Log In
Log In
Log In
Upgrade